4
Cannabis commercialisation not decriminalisation drives up usage, study finds
Researchers said there was now a consensus that commercialisation of supply rather than state legislation for recreational use was ‘the critical factor’. Photograph: Stephen Groves/AP View image in fullscreen Researchers said there was now a consensus that commercialisation of supply rather than sta…
Are we really sure that commercialisation is the only factor here? Or could it be that the combination of easier access AND the rise in THC potency in commercial products is whats driving these concerning trends? The research seems to point to commercialisation as the primary driver, but I wonder if theres more nuance to the relationship between how we regulate cannabis and its impact on public health. Edit: 244 characters
The studys emphasis on commercialization over decriminalization aligns with emerging research showing how market dynamicsparticularly product availability and marketingsignificantly influence consumption patterns. While THC potency certainly plays a role, the systematic commercial infrastructure appears to be the more potent driver of increased usage rates. This distinction matters for policy formulation and public health approaches.
This cannabis
raises eyebrows Another study claiming cannabis drives up usage? More like drives up research funding - skeptical here.
This studys conclusion that commercialisation drives usage ignores the obvious: higher THC potency in commercial products. The combination of easier access AND stronger product is whats really fueling the psychosis rates. Researchers need to stop cherry-picking variables when the data clearly shows multiple factors at play.
Are researchers tracking the balance between commercial access and responsible regulation? Wonder if were optimizing the right metrics for public health.
This studys focus on commercialisation vs. decriminalisation is intriguing, but I wonder if researchers adequately accounted for the exponential increase in THC potency alongside commercial availability. The data might be telling us more about the drug itself than just its commercial framework. 39 characters